<DOC>
	<DOCNO>NCT00666601</DOCNO>
	<brief_summary>The purpose study measure penetration TR-700 subcutaneous adipose tissue skeletal muscle single oral dose 600 mg TR-701</brief_summary>
	<brief_title>Microdialysis Pharmacokinetic Study TR-701</brief_title>
	<detailed_description>This study conduct two part : Pilot Study Main Study . The Pilot Study conduct assess recovery exogenously administer TR-700 ( microbiologically active moiety ) via microdialysis . In Main Study , pharmacokinetics TR-700 determine soft tissue ( via microdialysis ) plasma single oral dose 600 mg TR-701 ( prodrug ) .</detailed_description>
	<mesh_term>Torezolid phosphate</mesh_term>
	<mesh_term>Torezolid</mesh_term>
	<criteria>Body mass index 20 29 kg/m2 Agree consume product contain tobacco , alcohol , quinine , grapefruit , caffeine , high level tyramine Agree use medication Female subject must postmenopausal ( least 6 month ) , surgically sterile , abstinent , , sexually active , practice effective method birth control History gastric duodenal ulcer within 1 year enrollment Has know suspect hypersensitivity intolerance heparin , indwell cannula ( e.g. , heparin lock ) use Recent febrile illness ( le 72 hour first intake study medication ) . Significant blood loss ( 300 mL ) donation blood within 60 day Screening visit Women pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Microdialysis</keyword>
	<keyword>Antibiotic</keyword>
	<keyword>Healthy subject</keyword>
</DOC>